chikungunya virus advances in biology pathogenesis and treatment
Chikungunya Virus: Advances in Biology, Pathogenesis, and Treatment
$135.00 Original price was: $135.00.$4.99Current price is: $4.99. Add to cart
Sale!

Chikungunya Virus: Advances in Biology, Pathogenesis, and Treatment

Original price was: $135.00.Current price is: $4.99.

-96%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Emerging Arbovirus: Chikungunya Virus: Advances in Biology, Pathogenesis, and Treatment

Once confined to obscure tropical regions, the Chikungunya virus has exploded into a global public health threat, carried rapidly across continents by expanding populations of *Aedes* mosquitoes. While rarely fatal, the virus inflicts an excruciating, debilitating polyarthralgia (joint pain) that can persist for months or even years, crippling healthcare systems and economies. Chikungunya Virus: Advances in Biology, Pathogenesis, and Treatment is the definitive, fiercely specialized virology text dedicated to this emerging pathogen. This volume provides the exact blueprints required to understand the virus’s biology, its transmission cycle, and the search for a vaccine.

Mastering Viral Entry and Replication

The core philosophy of this text is molecular virology. The authors aggressively detail the structure of this positive-sense RNA alphavirus. It dictates exactly how the viral envelope glycoproteins mediate attachment and entry into human target cells (primarily fibroblasts and macrophages), and how the viral replication machinery hijacks the host cell’s resources to rapidly produce new virions.

Navigating the Vector and Host Immune Response

The book provides a masterclass in epidemiology and immunopathology. It dictates the exact clinical pathways for understanding the virus’s adaptation to the *Aedes albopictus* mosquito, a mutation that fueled its massive global expansion. It provides exhaustive reviews of the host immune response, exploring why some patients clear the infection rapidly while others develop a chronic, rheumatoid arthritis-like syndrome driven by persistent viral RNA or hyperactive macrophages in the joints.

Frequently Asked Questions (FAQs)

Does this book cover current vaccine trials?
Yes, it rigorously reviews the development pipeline for Chikungunya vaccines, detailing the mechanisms of live-attenuated and virus-like particle (VLP) candidates currently in clinical trials.

Who is the primary audience?
It is the absolute, mandatory reference for Virologists, Infectious Disease Specialists, Epidemiologists, and Public Health Officials.